These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9372554)

  • 1. Agonist-induced morphologic decrease in cellular D1A dopamine receptor staining.
    Ariano MA; Sortwell CE; Ray M; Altemus KL; Sibley DR; Levine MS
    Synapse; 1997 Dec; 27(4):313-21. PubMed ID: 9372554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
    Ventura AL; Sibley DR
    J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal neurochemical changes in transgenic models of Huntington's disease.
    Ariano MA; Aronin N; Difiglia M; Tagle DA; Sibley DR; Leavitt BR; Hayden MR; Levine MS
    J Neurosci Res; 2002 Jun; 68(6):716-29. PubMed ID: 12111832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.
    Lewis MM; Watts VJ; Lawler CP; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1998 Jul; 286(1):345-53. PubMed ID: 9655879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
    Tang FM; Sun YF; Wang R; Ding YM; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
    Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
    Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of dopamine receptors inhibited Ca2+-calmodulin-dependent protein kinase II activity in rat striatal slices.
    Hou XY; Tang FM; Zhang GY
    Acta Pharmacol Sin; 2001 Nov; 22(11):966-70. PubMed ID: 11749784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons.
    Martin-Negrier ML; Charron G; Bloch B
    Synapse; 2006 Sep; 60(3):194-204. PubMed ID: 16739117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes.
    Ariano MA; Sibley DR
    Brain Res; 1994 Jun; 649(1-2):95-110. PubMed ID: 7953659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T; Kotera J; Omori K
    J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
    Brusniak MY; Pearlman RS; Neve KA; Wilcox RE
    J Med Chem; 1996 Feb; 39(4):850-9. PubMed ID: 8632409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution of the rat D1B receptor in central nervous system using anti-receptor antisera.
    Ariano MA; Wang J; Noblett KL; Larson ER; Sibley DR
    Brain Res; 1997 Jan; 746(1-2):141-50. PubMed ID: 9037493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
    Kobayashi S; Ogren SO; Hoffer BJ; Olson L
    Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation.
    Wersinger C; Chen J; Sidhu A
    Mol Cell Neurosci; 2004 Jan; 25(1):124-37. PubMed ID: 14962746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1 receptor regulation of preprotachykinin-A gene by extracellular signal-regulated kinase pathway in striatal cultures.
    Sin M; Michelhaugh SK; Bannon MJ
    Neuroreport; 2008 Jan; 19(2):187-91. PubMed ID: 18185106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.